3 hours Seres Therapeutics, Inc. (NASDAQ:MCRB) Given Average Recommendation of “Moderate Buy” by AnalystsMarketBeat
Shares of Seres Therapeutics, Inc. (NASDAQ:MCRB – Get Free Report) have earned a consensus rating of “Moderate Buy” from the three ratings firms that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock wit…
X